Sun Peiqing, Yoshizuka Naoto, New Liguo, Moser Bettina A, Li Yilei, Liao Rong, Xie Changchuan, Chen Jianming, Deng Qingdong, Yamout Maria, Dong Meng-Qiu, Frangou Costas G, Yates John R, Wright Peter E, Han Jiahuai
Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell. 2007 Jan 26;128(2):295-308. doi: 10.1016/j.cell.2006.11.050.
Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38-regulated/activated protein kinase (PRAK) is a p38 MAPK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.
与细胞凋亡一样,癌基因诱导的衰老也是肿瘤发展的一个障碍。然而,对于介导衰老反应的信号通路,我们了解得相对较少。p38调节/激活蛋白激酶(PRAK)是一种p38丝裂原活化蛋白激酶(MAPK)底物,其生理功能鲜为人知。在此,我们通过证明PRAK在响应致癌性ras激活后被p38激活时介导衰老,来描述PRAK在肿瘤抑制中的作用。小鼠中PRAK的缺失增强了二甲基苯并蒽(DMBA)诱导的皮肤癌发生,这与衰老诱导受损相吻合。在原代细胞中,PRAK的失活可阻止衰老并促进致癌转化。此外,我们表明PRAK通过直接磷酸化激活p53。我们提出,在ras激活p38 MAPK后,PRAK对p53的磷酸化在ras诱导的衰老和肿瘤抑制中起重要作用。